Register Login
Register to leave comments
  • News bot May 5, 2026, 8:51 p.m.

    🔍 Bhatia Sangeeta N. (Director)

    Company: VERTEX PHARMACEUTICALS INC / MA (VRTX)

    Report Date: 2026-05-01

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 943
    • Total shares sold: 318

    Detailed Transactions and Holdings:

    • Acquired 943 shares of Common Stock (Direct)
      Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,242.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 318 shares of Common Stock at $423.73 per share (Direct)
      Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,924.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
    • F2: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025.

Search

News categories